Wird geladen...
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives
BACKGROUND: A core evaluation framework that captures the health care and societal benefits of value added medicines (VAMs, also often called repurposed medicines) was proposed in Report 1, aiming to reduce the heterogeneity in value assessment processes across countries and to create incentives for...
Gespeichert in:
| Veröffentlicht in: | Cost Eff Resour Alloc |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8280561/ https://ncbi.nlm.nih.gov/pubmed/34266465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12962-021-00296-2 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|